Autologous adipose-derived falciform mesenchymal stem cells in the management of canine chronic hepatitis/cirrhosis: clinical audit
I’ll try to flesh out these details over the next few weeks with some more post-treatment biochem results. As yet, no post-treatment histopathology is available. It should be pointed out that we would only consider stem cell therapy in a situation where the prognosis is, at the very least, guarded. That is reflected in … Continue reading
